Home > Boards > US Listed > Medical - Drugs > Merck & Co. Inc. (MRK)

FDA approves MRK’s Recarbrio (a combination of three

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 747
Posts 115,152
Boards Moderated 14
Alias Born 09/05/02
160x600 placeholder
Warren Buffett's Annual Letter Is About to Land Dow Jones News - 2/26/2021 1:58:00 PM
Merck requested to give more data on COVID-19 therapy for marketing approval Seeking Alpha - 2/26/2021 10:41:20 AM
Annual Report (10-k) Edgar (US Regulatory) - 2/25/2021 4:38:51 PM
Merck Animal Health Completes Acquisition of Poultry Sense Limited Business Wire - 2/25/2021 4:30:00 PM
Pandion Shares More Than Double Premarket on Takeover by Merck Dow Jones News - 2/25/2021 9:28:00 AM
Merck to Buy Pandion Therapeutics for $1.85 Billion Dow Jones News - 2/25/2021 7:28:00 AM
Merck to Acquire Pandion Therapeutics Business Wire - 2/25/2021 6:45:00 AM
Merck to Present at the Cowen 41st Annual Health Care Conference Business Wire - 2/24/2021 6:45:00 AM
Nektar and Merck team up in mid-stage cancer combo study Seeking Alpha - 2/17/2021 10:59:44 AM
Independent Data Monitoring Committee Concludes OlympiA Trial of LYNPARZA® (olaparib) Crossed Superiority Boundary for Invas... Business Wire - 2/17/2021 6:55:00 AM
Insiders at Covid-19 Vaccine Makers Sold Nearly $500 Million of Stock Last Year Dow Jones News - 2/17/2021 5:59:00 AM
Buffett's Berkshire Hathaway Bets Billions on Verizon and Chevron -- Update Dow Jones News - 2/16/2021 7:18:00 PM
Sesen price target raised on prospects for bladder cancer therapy Seeking Alpha - 2/16/2021 4:36:05 PM
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrated Superior Progression-Free Survival (PFS) & Overall Surviv... Business Wire - 2/13/2021 1:01:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/10/2021 6:51:00 PM
Merck’s Keytruda decision deferred Seeking Alpha - 2/10/2021 7:36:08 AM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 2/9/2021 4:28:39 PM
Merck antiviral molnupiravir effective in preventing COVID-19 in lung tissue Seeking Alpha - 2/9/2021 11:49:14 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2021 8:04:55 AM
Merck CFO Brings Corporate Strategy Experience to CEO Role Dow Jones News - 2/5/2021 5:59:00 AM
Merck's Kenneth Frazier to Retire as CEO at End of June -- 3rd Update Dow Jones News - 2/4/2021 5:14:00 PM
Merck's Kenneth Frazier to Retire as CEO at End of June -- 2nd Update Dow Jones News - 2/4/2021 1:03:00 PM
Merck's Kenneth Frazier to Retire as CEO at End of June -- Update Dow Jones News - 2/4/2021 9:59:00 AM
Correction to Merck's Frazier to Retire Article Dow Jones News - 2/4/2021 8:12:00 AM
Merck Posts 4Q Revenue Growth on Oncology, Vaccine Gains Dow Jones News - 2/4/2021 7:36:00 AM
DewDiligence Member Level  Thursday, 06/04/20 11:15:26 PM
Re: None
Post # of 585 
FDA approves MRK’s Recarbrio (a combination of three agents) for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia:

https://www.prnewswire.com/news-releases/fda-approves-antibiotic-to-treat-hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia-301071053.html

Recarbrio was previously FDA-approved for patients with complicated urinary tract infections and complicated intra-abdominal infections.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences